Clearmind Medicine Inc. (CMND): Consensus Target

Clearmind Medicine Inc. (CMND) acts as a biopharmaceutical pioneer, investing massive funds into neurobiological research to combat eating disorders and alcoholism. The company's operations rely on internal liquidity, rendering it independent of market cycles while conducting early-stage testing of psychedelic compounds. The price visualization assisting in the basic asset valuation, where the indicator stands at 0.00, complements data regarding the creation of unique synthetic agents designed to eliminate alcohol cravings.

CMND (clearmindmedicine.com) Analyst Consensus Forecast history from 04/28/2023 to 11/15/2026

Analytical breakdowns for Clearmind Medicine (CMND)

- market price and analyst price targets:

Stock Quotes Clearmind Medicine, Inc.|CMND - Price Target Chart

- stock exchange capitalization data:

Market Valuation Clearmind Medicine|CMND - Total Company Value

- book value of equity indicators:

Equity per Share Clearmind Medicine|CMND - Book Capitalization|Capitalization to Book Value Ratio clearmindmedicine.com|CMND - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Equity Clearmind Medicine Inc.|CMND - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Clearmind Medicine Inc.|CMND - Company Aggregate Debts|Debts to Book Capitalization Clearmind Medicine|CMND - Company Long-Term Debt|Company Short-Term Loans and Borrowings Clearmind Medicine|Quick Liquidity Indicator clearmindmedicine.com

- net income and valuation multiples indicators:

CMND - Net Profit|Projected Future Earnings Clearmind Medicine Inc.|CMND - Price to Earnings Ratio|Future Price to Earnings Multiple Clearmind Medicine, Inc.|CMND - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Clearmind Medicine|CMND - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Clearmind Medicine|CMND - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months clearmindmedicine.com|CMND - Earnings growth in current year|Expected earnings per share growth for next year Clearmind Medicine Inc.

- issuer revenue and sales details:

CMND - Revenue and Sales Volume|Company Future Revenue clearmindmedicine.com|CMND - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Clearmind Medicine Inc.|CMND - Sales Growth YoY (TTM)

General company analysis:CMND Clearmind Medicine, Inc.

Flagship merchandise of clearmindmedicine.com

The assessment of the asset's operational resilience is based on the consensus forecast of the security's market value, calculated as the average of target prices from leading analysts to determine the fundamental margin of safety. For Clearmind Medicine Inc. (CMND), this indicator is critically important, as it reflects market expectations regarding clinical trial outcomes against a backdrop of high R&D capital expenditure.

Competitors of Clearmind Medicine Inc.

Analyst Consensus Forecast Alkermes PLC (ALKS)|Avadel Pharma - Consensus Target|Analyst Forecast Prices ATAI (atai Life Sciences Corp)|GHRS - Price Target Chart|Mind Medicine (MNMD) - Consensus Target|COMPASS Pathways PLC (CMPS) - Price Target Chart|Broker Consensus Forecast LBRX|Price Target Chart Bright Minds Biosciences Inc.|Vanda Pharmaceuticals Inc - Forecast Levels Chart|Analyst Consensus Forecast CYBN|ANRO (Alto Neuroscience, Inc.) - Fair Value Consensus|Analyst Consensus Forecast NRXP (nrxpharma.com)|Analyst Consensus Forecast Cingulate Inc. CING|SILO - Price Target Chart|Fair Value Consensus CPHI (China Pharma Holdings, Inc.)|PBM: Analyst Consensus Forecast|Consensus Target SciSparc Ltd|SEEL (seelostherapeutics.com) - Analyst Consensus Forecast|Analyst Consensus Forecast Virpax Pharmaceuticals, Inc.|Consensus Target KRTX (Karuna)